✦ LIBER ✦

The HIV-1 protease resistance mutation I50L is associated with resistance to atazanavir and susceptibility to other protease inhibitors in multiple mutational contexts

✍ Scribed by P. Sista; B. Wasikowski; P. Lecocq; T. Pattery; L. Bacheler

Book ID: 119292686
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 205 KB
Volume: 42
Category: Article
ISSN: 1386-6532
DOI: 10.1016/j.jcv.2008.03.023

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The HIV Type 1 Protease L10I Minor Mutat

The HIV Type 1 Protease L10I Minor Mutation Decreases Replication Capacity and Confers Resistance to Protease Inhibitors

✍ Flor-Parra, Fernando; Pérez-Pulido, Antonio J.; Pachón, Jerónimo; Pérez-Romero, 📂 Article 📅 2011 🏛 Mary Ann Liebert 🌐 English ⚖ 261 KB

The cumulative occurrence of resistance

The cumulative occurrence of resistance mutations in the HIV-1 protease gene is associated with failure of salvage therapy with ritonavir and saquinavir in protease inhibitor-experienced patients

✍ Marina Karmochkine; Ali Si Mohamed; Christophe Piketty; Christine Ginsburg; Gill 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Changes in the Vif protein of HIV-1 asso

Changes in the Vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease

✍ Melanie A. Adekale; Patricia A. Cane; Malcolm A. McCrae 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

## Abstract The protease (__PR__) and virus infectivity factor (__vif__) gene sequences of a cohort of HIV‐1 infected patients showing evidence of developing protease inhibitor (PI) resistance whilst undergoing highly active antiretroviral therapy (HAART) have been determined. The PR sequences show

Drug resistance mutations and newly reco

Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: Prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients

✍ Carlo Torti; Eugenia Quiros-Roldan; Laura Monno; Andrea Patroni; Annalisa Saraci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 1 views

## Abstract This study aimed at identifying HIV‐1 protease amino acid changes associated with protease inhibitor (PI) exposure and susceptibility. New amino acid substitutions were correlated with the number of experienced PIs, reaching statistical significance only for those at positions 3, 44, an